# RABEPRAZOLE SODIUM
> **ANDA205761** · Abbreviated New Drug Application (Generic) · Sponsor: AUROBINDO PHARMA USA · Approved 2017-02-17
## Drug
- **FDA Application Number:** ANDA205761
- **Application type:** Abbreviated New Drug Application (Generic)
- **Brand name:** RABEPRAZOLE SODIUM
- **Generic name:** RABEPRAZOLE SODIUM
- **Active ingredients:** RABEPRAZOLE SODIUM
- **Dosage form:** TABLET, DELAYED RELEASE
- **Route:** ORAL
- **Marketing status:** Prescription
- **Sponsor:** AUROBINDO PHARMA USA
- **Manufacturer:** Aurobindo Pharma Limited
- **First approval:** 2017-02-17
## Source
- [Drugs@FDA application overview](https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=205761)
---
*AI Analytics · CC0 1.0*